Dan Leonard
Stock Analyst at RBC Capital
(4.75)
# 646
Out of 4,969 analysts
519
Total ratings
61.5%
Success rate
14.4%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Initiated Coverage: Hold | $1,350 → $1,515 | $1,285.75 | +17.83% | 15 | Sep 1, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | $115 → $135 | $128.49 | +5.07% | 19 | Sep 1, 2026 | |
| TXG 10x Genomics | Initiated Coverage: Hold | $20 → $70 | $70.11 | -0.16% | 4 | Sep 1, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $153 → $185 | $146.80 | +26.02% | 36 | Aug 26, 2026 | |
| WAT Waters | Reiterated: Buy | $475 | $410.01 | +15.85% | 26 | Aug 24, 2026 | |
| TECH Bio-Techne | Reiterated: Hold | $73 | $72.27 | +1.01% | 22 | Aug 12, 2026 | |
| ILMN Illumina | Reiterated: Buy | $230 | $208.21 | +10.47% | 42 | Aug 10, 2026 | |
| BIO Bio-Rad Laboratories | Reiterated: Buy | $320 → $390 | $368.55 | +5.82% | 30 | Aug 6, 2026 | |
| NTRA Natera | Rated: Buy | $275 → $350 | $341.79 | +2.40% | 19 | Aug 6, 2026 | |
| GH Guardant Health | Rated: Buy | $185 → $200 | $167.84 | +19.16% | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $14 | $15.16 | -7.65% | 13 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $185 | $168.00 | +10.12% | 5 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $490 → $580 | $613.62 | -5.48% | 28 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $215 | $203.25 | +5.78% | 27 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $52.66 | -14.55% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $10 | $8.00 | +25.00% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $170 → $175 | $273.11 | -35.92% | 19 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $355 → $340 | $355.20 | -4.28% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $52 | $41.88 | +24.16% | 17 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $280 → $240 | $265.67 | -9.66% | 17 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $13 | $15.96 | -21.68% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 → $220 | $168.94 | +30.22% | 7 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $28 | $21.32 | n/a | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $300 → $305 | $595.41 | n/a | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $20 | $20.65 | n/a | 6 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $6.69 | n/a | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 → $7 | $24.78 | n/a | 2 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 → $320 | $315.31 | n/a | 15 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $160 → $145 | $237.89 | n/a | 15 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $86 → $95 | $122.20 | n/a | 7 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.22 | n/a | 1 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $35 | $3.79 | n/a | 14 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $182.91 | n/a | 1 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.001 | n/a | 5 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $52.37 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $41.21 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $103.09 | n/a | 1 | Jun 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.000001 | n/a | 4 | May 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.5 | $1.31 | n/a | 3 | May 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $0.6965 | n/a | 11 | Apr 12, 2016 |
Mettler-Toledo International
Sep 1, 2026
Initiated Coverage: Hold
Price Target: $1,350 → $1,515
Current: $1,285.75
Upside: +17.83%
Revvity
Sep 1, 2026
Initiated Coverage: Hold
Price Target: $115 → $135
Current: $128.49
Upside: +5.07%
10x Genomics
Sep 1, 2026
Initiated Coverage: Hold
Price Target: $20 → $70
Current: $70.11
Upside: -0.16%
Agilent Technologies
Aug 26, 2026
Reiterated: Buy
Price Target: $153 → $185
Current: $146.80
Upside: +26.02%
Waters
Aug 24, 2026
Reiterated: Buy
Price Target: $475
Current: $410.01
Upside: +15.85%
Bio-Techne
Aug 12, 2026
Reiterated: Hold
Price Target: $73
Current: $72.27
Upside: +1.01%
Illumina
Aug 10, 2026
Reiterated: Buy
Price Target: $230
Current: $208.21
Upside: +10.47%
Bio-Rad Laboratories
Aug 6, 2026
Reiterated: Buy
Price Target: $320 → $390
Current: $368.55
Upside: +5.82%
Natera
Aug 6, 2026
Rated: Buy
Price Target: $275 → $350
Current: $341.79
Upside: +2.40%
Guardant Health
Jul 31, 2026
Rated: Buy
Price Target: $185 → $200
Current: $167.84
Upside: +19.16%
Jul 29, 2026
Reiterated: Hold
Price Target: $9 → $14
Current: $15.16
Upside: -7.65%
Jul 28, 2026
Reiterated: Buy
Price Target: $160 → $185
Current: $168.00
Upside: +10.12%
Jul 23, 2026
Reiterated: Hold
Price Target: $490 → $580
Current: $613.62
Upside: -5.48%
Jul 21, 2026
Reiterated: Buy
Price Target: $200 → $215
Current: $203.25
Upside: +5.78%
May 7, 2026
Rated: Hold
Price Target: $40 → $45
Current: $52.66
Upside: -14.55%
Mar 9, 2026
Rated: Buy
Price Target: $15 → $10
Current: $8.00
Upside: +25.00%
Feb 25, 2026
Reiterated: Hold
Price Target: $170 → $175
Current: $273.11
Upside: -35.92%
Feb 13, 2026
Reiterated: Buy
Price Target: $355 → $340
Current: $355.20
Upside: -4.28%
Feb 9, 2026
Reiterated: Hold
Price Target: $52
Current: $41.88
Upside: +24.16%
Feb 6, 2026
Reiterated: Buy
Price Target: $280 → $240
Current: $265.67
Upside: -9.66%
Nov 5, 2025
Reiterated: Buy
Price Target: $11 → $13
Current: $15.96
Upside: -21.68%
Oct 24, 2025
Reiterated: Buy
Price Target: $260 → $220
Current: $168.94
Upside: +30.22%
Aug 6, 2025
Reiterated: Hold
Price Target: $24 → $28
Current: $21.32
Upside: n/a
Jul 29, 2025
Downgraded: Sell
Price Target: $300 → $305
Current: $595.41
Upside: n/a
Mar 2, 2025
Reiterated: Hold
Price Target: $25 → $20
Current: $20.65
Upside: n/a
Aug 8, 2024
Reiterated: Hold
Price Target: $11
Current: $6.69
Upside: n/a
Feb 14, 2023
Reiterated: Sell
Price Target: $8 → $7
Current: $24.78
Upside: n/a
Feb 11, 2022
Reiterated: Buy
Price Target: $340 → $320
Current: $315.31
Upside: n/a
Feb 4, 2022
Reiterated: Hold
Price Target: $160 → $145
Current: $237.89
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $86 → $95
Current: $122.20
Upside: n/a
Jul 14, 2020
Initiated Coverage: Buy
Price Target: $11
Current: $0.22
Upside: n/a
Aug 14, 2019
Reiterated: Hold
Price Target: $45 → $35
Current: $3.79
Upside: n/a
Dec 6, 2018
Initiated Coverage: Buy
Price Target: $280
Current: $182.91
Upside: n/a
Jul 8, 2016
Reiterated: Buy
Price Target: $7
Current: $0.001
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $52.37
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $41.21
Upside: n/a
Jun 16, 2016
Rated: Hold
Price Target: n/a
Current: $103.09
Upside: n/a
May 23, 2016
Reiterated: Buy
Price Target: $4
Current: $0.000001
Upside: n/a
May 11, 2016
Reiterated: Hold
Price Target: $4.5 → $3.5
Current: $1.31
Upside: n/a
Apr 12, 2016
Reiterated: Buy
Price Target: $20 → $15
Current: $0.6965
Upside: n/a